Intelligence · Patents
Expiring patents (≤24 months)
Patent cliff watchlist — pharmaceutical patents approaching loss of exclusivity.
- Patents
- 1,230
Quick answer
1,230 pharmaceutical patents in our index expire within the next 24 months. Use year facets below for annual patent-cliff planning linked to company and drug profiles.
-
US 7226937
Methods for modulating phototoxicity
granted -
US 7226950
Sodium channel modulators
granted -
US 7227009
MT-SP1 polynucleotides and polypeptides
granted -
US 7226991
Phenylalanine derivatives
granted -
US 7227010
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
granted -
US 7229628
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
granted -
US 7229627
Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
granted -
US 7229963
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
granted -
US 7229604
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
granted -
US 7229770
YKL-40 as a marker and prognostic indicator for cancers
granted -
US 7229826
Process for ex vivo formation of mammalian bone and uses thereof
granted -
US 7229949
Safe delivery system for agriculturally active material
granted -
US 7229641
Rapid-melt compositions methods of making same and methods of using same
granted -
US 7230086
Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
granted -
US 7229995
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 7230004
Cyclopamine analogues and methods of use thereof
granted -
US 7229986
Melanin-concentrating hormone antagonist
granted -
US 7229972
3,6-Bicyclolides
granted -
US 7232671
Pertussis toxin gene: cloning and expression of protective antigen
granted -
US 7232887
Melanoma antigens and their use in diagnostic and therapeutic methods
granted -
US 7232566
Methods for treating HIV infected subjects
granted -
US 7232684
DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
granted -
US 7232570
ERAAP modulators regulate immune responses
granted -
US 7232890
AIB1, a novel steroid receptor co-activator
granted -
US 7235573
Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
granted -
US 7235644
Vaccine against Gram-negative bacterial infections
granted -
US 7235232
Interferon alpha hybrids
granted -
US 7235228
Fluorescent-magnetic nanoparticles with core-shell structure
granted -
US 7235365
Specific binding agents for KSHV vIL-6 that neutralize a biological activity
granted -
US 7235529
Brain-associated inhibitor of tissue-type plasminogen activator
granted -
US 7235534
Antisense strategy to modulate estrogen receptor response (ER α and/or ER β )
granted -
US 7235234
Bacterial delivery system
granted -
US 7235236
Polynucleotide encoding human adenylylcyclase VI and uses thereof for enhancing cardiac function
granted -
US 7235531
Tachykinin-like polypeptides and use thereof
granted -
US 7235577
Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
granted -
US 7235691
Crystalline forms of modafinil
granted -
US 7238525
Strategy for leukemia therapy
granted -
US 7238475
Apolipoprotein gene involved in lipid metabolism
granted -
US 7238489
Identification of sortase gene
granted -
US 7238369
Cationic liposome delivery of taxanes to angiogenic blood vessels
granted -
US 7238366
Submicron liposome suspensions obtained from preliposome lyophilizates
granted -
US 7238708
Glucose sensor
granted -
US 7238713
Muscarinic agonists
granted -
US 7238709
Therapeutic carbamates
granted -
US 7238800
Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections
granted -
US 7238673
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
granted -
US 7238716
Alkanoic acid derivatives process for their production and use thereof
granted -
US 7241785
Five-membered heterocyclic alkanoic acid derivative
granted
Frequently asked questions
What is a patent cliff?
A patent cliff is when key pharmaceutical patents expire, opening markets to generics or biosimilars. This hub lists USPTO patents with approaching expiration dates.
Are expiration dates estimates?
Expiration dates derive from USPTO PatentsView grant dates and term estimates. Confirm with Orange Book, patent counsel, and USPTO records before investment decisions.